PedraTech is a biotechnology startup based in Singapore, founded in 2013, with a focus on developing perfusion technologies for the diagnosis and management of peripheral artery disease. Their slogan, "Real-time perfusion tracking in the angio suite. Accurate ischemic foot triage on the frontline," encapsulates their commitment to leveraging real-time data for more effective patient care. The company recently received a significant boost with a $4.70M Series A investment on 22nd September 2020, with funding from SEEDS Capital and M&L Healthcare Investments. This injection of capital will undoubtedly support their continued innovation and expansion. With a clear vision and support from notable investors, PedraTech is primed to make a meaningful impact in the biotechnology and healthcare industries.
No recent news or press coverage available for PedraTech.